Peter A Fasching Selected Research

Peter A Fasching Research Topics

Disease

325	Breast Neoplasms (Breast Cancer) 04/2024 - 12/2005
170	Neoplasms (Cancer) 05/2024 - 12/2006
37	Triple Negative Breast Neoplasms 04/2024 - 06/2014
23	Ovarian Neoplasms (Ovarian Cancer) 05/2024 - 01/2011
18	Pathologic Complete Response 11/2023 - 04/2010
14	Carcinoma (Carcinomatosis) 01/2023 - 04/2010
13	Circulating Neoplastic Cells 01/2024 - 07/2011
12	Ovarian Epithelial Carcinoma 11/2023 - 06/2011
10	Endometriosis 08/2023 - 11/2009
9	Endometrial Neoplasms (Endometrial Cancer) 04/2021 - 01/2006
7	Disease Progression 12/2023 - 01/2011
6	Neutropenia 01/2023 - 01/2013
6	Neoplasm Metastasis (Metastasis) 10/2021 - 12/2008
5	Nausea 03/2024 - 01/2010
4	Vomiting 03/2024 - 07/2010
4	Cardiotoxicity 01/2022 - 04/2010
4	Pain (Aches) 08/2021 - 01/2010
4	Inflammation (Inflammations) 01/2021 - 07/2013
3	Leukopenia 03/2024 - 01/2018
3	Fatigue 01/2023 - 11/2018
3	Residual Neoplasm 09/2022 - 01/2019
3	Brain Neoplasms (Brain Tumor) 06/2022 - 12/2018
3	Amenorrhea 01/2021 - 10/2019

Drug/Important Bio-Agent (IBA)

103	Hormones (Hormone)IBA 04/2024 - 01/2007
60	Estrogen ReceptorsIBA 02/2023 - 01/2006
49	Biomarkers (Surrogate Marker)IBA 04/2024 - 04/2009
27	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2008
26	Progesterone Receptors (Progesterone Receptor)IBA 02/2023 - 12/2006
23	human ERBB2 proteinIBA 03/2024 - 04/2010
23	Phenobarbital (Luminal)FDA Link 11/2023 - 01/2011
23	AnthracyclinesIBA 01/2022 - 04/2010
20	taxaneIBA 04/2022 - 04/2010
19	ErbB Receptors (EGF Receptor)IBA 04/2024 - 04/2010
18	Trastuzumab (Herceptin)FDA Link 10/2023 - 04/2010
18	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 12/2008
18	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 04/2010
16	Paclitaxel (Taxol)FDA LinkGeneric 03/2024 - 01/2011
15	Epirubicin (Ellence)FDA LinkGeneric 01/2023 - 04/2010
13	Estrogens (Estrogen)FDA Link 05/2021 - 12/2006
12	Letrozole (Femara)FDA LinkGeneric 03/2024 - 02/2014
11	ribociclibIBA 03/2024 - 01/2018
11	Bevacizumab (Avastin)FDA Link 12/2023 - 01/2012
11	Messenger RNA (mRNA)IBA 01/2023 - 01/2008
10	Carboplatin (JM8)FDA LinkGeneric 10/2022 - 06/2014
10	MicroRNAs (MicroRNA)IBA 10/2018 - 06/2011
9	Aromatase InhibitorsIBA 03/2024 - 01/2017
9	Fulvestrant (Faslodex)FDA Link 05/2023 - 01/2018
9	Tamoxifen FDA LinkGeneric 11/2021 - 01/2006
9	Docetaxel (Taxotere)FDA Link 01/2019 - 04/2010
8	PlatinumIBA 03/2024 - 06/2014
8	Transcription Factors (Transcription Factor)IBA 01/2020 - 04/2013
7	olaparibIBA 12/2023 - 01/2019
7	pembrolizumabIBA 08/2023 - 01/2020
7	Poly(ADP-ribose) Polymerase InhibitorsIBA 03/2023 - 03/2018
7	ORALIT (ORS)IBA 01/2023 - 05/2009
6	Immunoconjugates (Immunoconjugate)IBA 03/2024 - 01/2019
6	Epidermal Growth Factor (EGF)IBA 12/2023 - 10/2011
6	130-nm albumin-bound paclitaxelIBA 11/2023 - 01/2019
6	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2008
6	Oral ContraceptivesIBA 01/2023 - 01/2013
6	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2022 - 01/2013
6	Immune Checkpoint InhibitorsIBA 06/2022 - 10/2016
6	Capecitabine (Xeloda)FDA Link 06/2021 - 04/2010
6	pertuzumabIBA 06/2021 - 01/2019
5	exemestane (Aromasin)FDA Link 03/2024 - 01/2018
5	Everolimus FDA Link 03/2024 - 02/2012
5	palbociclibIBA 12/2023 - 01/2021
5	Diphosphonates (Bisphosphonates)IBA 08/2021 - 01/2013
4	ChromatinIBA 05/2024 - 01/2015
4	Anastrozole (Arimidex)FDA LinkGeneric 03/2024 - 05/2010
4	LigandsIBA 01/2024 - 01/2017
4	Denosumab FDA Link 11/2023 - 01/2017
4	abemaciclibIBA 06/2023 - 01/2023
4	Cyclin-Dependent Kinase 4IBA 01/2023 - 01/2021
4	TabletsIBA 01/2022 - 01/2017
4	Zoledronic Acid (Zometa)FDA Link 08/2021 - 02/2014
4	Ado-Trastuzumab EmtansineIBA 10/2020 - 01/2019
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 01/2012
4	3' Untranslated Regions (3' UTR)IBA 11/2016 - 01/2014
3	Lapatinib (GW572016)FDA Link 01/2024 - 08/2014
3	talazoparibIBA 10/2023 - 01/2019
3	ethyl glucuronideIBA 08/2023 - 04/2010
3	sacituzumab govitecanIBA 03/2023 - 04/2021
3	Formaldehyde (Formol)FDA Link 01/2023 - 10/2014
3	AlpelisibIBA 06/2022 - 01/2019
3	Taxoids (Taxanes)IBA 10/2021 - 01/2011
3	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2021 - 01/2013
3	Gemcitabine FDA Link 10/2020 - 09/2015
3	Aromatase (CYP19)IBA 01/2020 - 01/2008

Therapy/Procedure

117	Therapeutics 04/2024 - 12/2005
73	Drug Therapy (Chemotherapy) 03/2024 - 01/2010
68	Neoadjuvant Therapy 11/2023 - 04/2010
14	Adjuvant Chemotherapy 08/2022 - 01/2011
7	Radiotherapy 02/2024 - 07/2014
7	Mastectomy (Mammectomy) 01/2020 - 12/2008
6	Precision Medicine 04/2024 - 11/2018
6	Immunotherapy 03/2024 - 10/2019
4	Combination Drug Therapy (Combination Chemotherapy) 03/2024 - 01/2018
4	Chemoprevention 01/2017 - 01/2007
3	Cytoreduction Surgical Procedures 01/2023 - 12/2015